Filings

7 documents · 16 matches

1. RAPP Rapport Therapeutics, Inc. 10-Q 2026-08-05

   Item 1A. Risk Factors.

   material weaknesses in our internal controls over financial reporting. Any failure to maintain effective disclosure controls and internal control over
   3 matches in this document Show context Copy citation

2. RAPP Rapport Therapeutics, Inc. 10-Q 2026-11-04

   Item 1A. Risk Factors.

   such standards, rules and regulations or to have significant deficiencies or material weaknesses in our internal controls over financial reporting.
   3 matches in this document Show context Copy citation

3. RAPP Rapport Therapeutics, Inc. 10-Q 2026-05-07

   Item 1A. Risk Factors.

   material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further
   2 matches in this document Show context Copy citation

4. RAPP Rapport Therapeutics, Inc. 10-K 2026-03-10

   Item 1A. Risk Factors.

   material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further
   2 matches in this document Show context Copy citation

5. RAPP Rapport Therapeutics, Inc. 10-Q 2025-11-06

   Item 1A. Risk Factors.

   material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further
   2 matches in this document Show context Copy citation

6. RAPP Rapport Therapeutics, Inc. 10-Q 2025-08-07

   Item 1A. Risk Factors.

   material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further
   2 matches in this document Show context Copy citation

7. RAPP Rapport Therapeutics, Inc. 10-Q 2025-05-08

   Item 1A. Risk Factors.

   material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further
   2 matches in this document Show context Copy citation